Neuroblastoma Global Clinical Trials Review, H1, 2018

  • ID: 4539003
  • Clinical Trials
  • Region: Global
  • 308 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • APEIRON Biologics AG
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Pfizer Inc
  • United Therapeutics Corp
  • MORE
Neuroblastoma Global Clinical Trials Review, H1, 2018

Summary

The clinical trial report, “Neuroblastoma Global Clinical Trials Review, H1, 2018" provides an overview of Neuroblastoma clinical trials scenario. This report provides top line data relating to the clinical trials on Neuroblastoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Clinical Trial Reports are generated using the author's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • APEIRON Biologics AG
  • AstraZeneca Plc
  • F. Hoffmann-La Roche Ltd
  • Novartis AG
  • Pfizer Inc
  • United Therapeutics Corp
  • MORE
  • Report Guidance
  • Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Neuroblastoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Neuroblastoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Neuroblastoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Neuroblastoma
  • Mar 21, 2018: Autolus Announces Oral Presentation at the AACR Annual Meeting of a Phase I study of a GD2 CAR-T Cell Therapy in Patients with Neuroblastoma
  • Mar 19, 2018: Karyopharm to Present Preclinical Data on Selinexor at the American Association for Cancer Research 2018 Annual Meeting
  • Mar 01, 2018: EnGeneIC Announces Publication of Preclinical Data Highlighting Potential Efficacy of EGFR-Targeted EDV Nanocells to Treat Pediatric Neuroblastoma
  • Clinical Trial Profile Snapshots
  • Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About
  • Contact
  • Disclaimer
  • Source
List of Tables
  • Neuroblastoma Therapeutics, Global, Clinical Trials by Region, 2018*
  • Neuroblastoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Neuroblastoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, North America, Top Countries, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2018*
  • Proportion of Neuroblastoma to Oncology Clinical Trials, G7 Countries (%), 2018*
  • Neuroblastoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Neuroblastoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Neuroblastoma to Oncology Clinical Trials, E7 Countries (%), 2018*
  • Neuroblastoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Neuroblastoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Neuroblastoma Therapeutics, Global, Clinical Trials by Phase, 2018*
  • Neuroblastoma Therapeutics, Global, Clinical Trials In Progress by Phase 2018*
  • Neuroblastoma Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Neuroblastoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
List of Figures
  • Neuroblastoma Therapeutics, Global, Clinical Trials by Region (%), 2018*
  • Neuroblastoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
  • Neuroblastoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
  • Neuroblastoma Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018*
  • Proportion of Neuroblastoma to Oncology Clinical Trials, G7 Countries (%), 2018*
  • Neuroblastoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
  • Neuroblastoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
  • Proportion of Neuroblastoma to Oncology Clinical Trials, E7 Countries (%), 2018*
  • Neuroblastoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
  • Neuroblastoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
  • Neuroblastoma Therapeutics, Global, Clinical Trials by Phase (%), 2018*
  • Neuroblastoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2018*
  • Neuroblastoma Therapeutics, Global, Clinical Trials by Trial Status, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Global, by End Point Status, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017
  • Neuroblastoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
  • Neuroblastoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
  • Methodology
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • F. Hoffmann-La Roche Ltd
  • Progenics Pharmaceuticals Inc
  • United Therapeutics Corp
  • Novartis AG
  • APEIRON Biologics AG
  • Pfizer Inc
  • Y-mAbs Therapeutics Inc
  • Children’s Cancer and Leukaemia Group
  • Children's Healthcare of Atlanta Inc
  • AstraZeneca Plc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll